ReviewJournal of neurology2022
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives.
Monica Margoni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
74 papers cite itlatest 60 shown
this paperpooled ittrialcites it